|
EP1123314B1
(en)
*
|
1998-10-20 |
2004-02-18 |
Vlaams Interuniversitair Instituut voor Biotechnologie vzw. |
Use of a cytokine-producing lactococcus strain to treat colitis
|
|
AUPQ291499A0
(en)
*
|
1999-09-17 |
1999-10-07 |
Women's And Children's Hospital Adelaide |
Novel nitro and sulphur containing compounds
|
|
NO328803B1
(no)
*
|
2000-03-03 |
2010-05-18 |
Thia Medica |
Nye fettsyreanaloger
|
|
CN101632669B
(zh)
*
|
2000-08-04 |
2011-05-18 |
Dmi生物科学公司 |
二酮基哌嗪和包含它们的组合物的使用方法
|
|
NO20006008L
(no)
*
|
2000-11-28 |
2002-05-29 |
Thia Medica As |
Fettsyreanaloger for behandling av inflammatoriske og autoimmune sykdommer
|
|
US7780961B2
(en)
*
|
2001-05-03 |
2010-08-24 |
Actogenix N.V. |
Self-containing Lactococcus strain
|
|
AU2003279761B2
(en)
*
|
2002-10-02 |
2009-11-12 |
Luoxis Diagnostics, Inc. |
Diagnosis and monitoring of diseases
|
|
CA2506031A1
(en)
*
|
2002-11-15 |
2004-06-03 |
Vib Vzw |
Self-containing lactobacillus strain comprising a thya mutation and therapeutic applications thereof
|
|
GB0311081D0
(en)
*
|
2003-05-14 |
2003-06-18 |
Btg Internat Limted |
Treatment of neurodegenerative conditions
|
|
KR20150080004A
(ko)
|
2003-05-15 |
2015-07-08 |
앰피오 파마슈티컬스 인코퍼레이티드 |
Ｔ-세포 매개성 질환의 치료 방법
|
|
ES2304094B2
(es)
*
|
2003-08-18 |
2010-10-14 |
Btg International Limited |
Tratamiento de dolencias neurodegenerativas.
|
|
DE10351111A1
(de)
*
|
2003-11-03 |
2005-06-16 |
Langlotz, Rainer |
Arzneimittel und Verfahren zu ihrer Herstellung
|
|
JP2007522118A
(ja)
*
|
2004-01-30 |
2007-08-09 |
ペプリン バイオリピッズ ピーティーワイ エルティーディー |
治療用分子および担体分子
|
|
US7544714B2
(en)
*
|
2004-07-16 |
2009-06-09 |
University Of Massachusetts |
Lipid-amino acid conjugates and methods of use
|
|
GB0425932D0
(en)
*
|
2004-11-25 |
2004-12-29 |
Btg Int Ltd |
Structured phospholipids
|
|
GB0504362D0
(en)
*
|
2005-03-02 |
2005-04-06 |
Btg Int Ltd |
Cytokine modulators
|
|
GB0504333D0
(en)
*
|
2005-03-02 |
2005-04-06 |
Btg Int Ltd |
Treatment of cytokine dysregulation
|
|
US20060246115A1
(en)
*
|
2005-03-04 |
2006-11-02 |
Ricardo Rueda |
Nutritional products for ameliorating symptoms of rheumatoid arthritis
|
|
ES2596855T3
(es)
|
2005-11-29 |
2017-01-12 |
Intrexon Actobiotics Nv |
Inducción de tolerancia mucosa a antígenos
|
|
JP2010516269A
(ja)
|
2007-01-25 |
2010-05-20 |
アクトジェニックス・エヌブイ |
抗原の粘膜送達による免疫疾患の治療
|
|
AU2008274876A1
(en)
*
|
2007-02-05 |
2009-01-15 |
Children, Youth And Women's Health Service |
Modulators of antigen-dependent T cell proliferation
|
|
JP5620272B2
(ja)
|
2007-11-09 |
2014-11-05 |
プロノヴァ・バイオファーマ・ノルゲ・アーエスＰｒｏｎｏｖａ ＢｉｏＰｈａｒｍａ ＮｏｒｇｅＡＳ |
化粧品において，食品サプリメントとして，または医薬品として用いるための脂質化合物
|
|
WO2009146320A1
(en)
|
2008-05-27 |
2009-12-03 |
Dmi Life Sciences, Inc. |
Therapeutic methods and compounds
|
|
EP2147910A1
(en)
|
2008-07-15 |
2010-01-27 |
Pronova BioPharma Norge AS |
Novel lipid compounds
|
|
EP2427415B1
(en)
*
|
2009-05-08 |
2019-03-20 |
Basf As |
Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas
|
|
GB0909643D0
(en)
*
|
2009-06-04 |
2009-07-22 |
Avexxin As |
Glomerulonephritis treatment
|
|
GB201014633D0
(en)
|
2010-09-02 |
2010-10-13 |
Avexxin As |
Rheumatoid arthritis treatment
|
|
JP2013537195A
(ja)
|
2010-09-07 |
2013-09-30 |
ディエムアイ アクイジション コーポレイション |
疾患の治療
|
|
AU2011324909B2
(en)
|
2010-11-05 |
2016-09-08 |
Pronova Biopharma Norge As |
Methods of treatment using lipid compounds
|
|
AU2012323305B2
(en)
|
2011-10-10 |
2017-07-27 |
Ampio Pharmaceuticals, Inc. |
Treatment of degenerative joint disease
|
|
BR112014007657A2
(pt)
|
2011-10-10 |
2017-04-11 |
Ampio Pharmaceuticals Inc |
dispositivos médicos implantáveis com tolerância imune aperfeiçoada e métodos para produção e implantação
|
|
MX355446B
(es)
|
2011-10-28 |
2018-04-18 |
Ampio Pharmaceuticals Inc |
Tratamiento de rinitis.
|
|
GB201205394D0
(en)
|
2012-03-27 |
2012-05-09 |
Adlens Ltd |
Improvements in or relating to deformable non-round membrane assemblies
|
|
CA2868077C
(en)
|
2012-03-30 |
2020-09-29 |
Givaudan S.A. |
Powder flavour composition
|
|
EP2830439B1
(en)
|
2012-03-30 |
2020-11-04 |
Givaudan SA |
N-acyl-gaba derivatives for the improvement of the flavour profile of edible compositions
|
|
EP2833739B1
(en)
|
2012-03-30 |
2020-12-02 |
Givaudan SA |
N-acyl proline derivatives as food flavouring compounds
|
|
BR112014023448B1
(pt)
|
2012-03-30 |
2021-06-22 |
Givaudan Sa |
Composição comestível ou bebida compreendendo derivados de n-acila de ácido gama amino-butírico e solução padrão
|
|
EP2830440B1
(en)
|
2012-03-30 |
2019-03-20 |
Givaudan SA |
N-acyl-aminocyclopropyl carboxylic acids as food flavouring compounds
|
|
WO2013149008A2
(en)
*
|
2012-03-30 |
2013-10-03 |
Givaudan, S.A. |
Improvements in or relating to organic compounds
|
|
CA2868058C
(en)
|
2012-03-30 |
2019-12-17 |
Givaudan S.A. |
N-acylated methionine derivatives as food flavouring compounds
|
|
JP6248092B2
(ja)
|
2012-03-30 |
2017-12-13 |
ジボダン エス エー |
食品フレーバー付与化合物としてのｎ−アシル化１−アミノシクロアルキルカルボン酸
|
|
GB201221329D0
(en)
|
2012-11-27 |
2013-01-09 |
Avexxin As |
Dermatitis treatment
|
|
EP3578170A1
(en)
|
2013-02-28 |
2019-12-11 |
Basf As |
A composition comprising a lipid compound, a triglyceride, and a surfactant, and methods of using the same
|
|
BR112015020469A2
(pt)
|
2013-03-15 |
2020-01-28 |
Ampio Pharmaceuticals Inc |
Usos de da-dkp, composição e método para fornecimento de células-tronco a umindivíduo
|
|
US10834950B2
(en)
|
2013-10-02 |
2020-11-17 |
Givaudan S.A. |
Organic compounds
|
|
WO2015048991A1
(en)
|
2013-10-02 |
2015-04-09 |
Givaudan Sa |
Organic compounds having taste-modifying properties
|
|
WO2015050535A1
(en)
|
2013-10-02 |
2015-04-09 |
Givaudan S.A. |
Organic compounds
|
|
EP3052472B1
(en)
|
2013-10-02 |
2019-02-27 |
Givaudan S.A. |
N-acylated 2-aminoisobutyric acid compounds and flavour compositions containing them
|
|
EP3057446B1
(en)
|
2013-10-02 |
2017-12-06 |
Givaudan S.A. |
Organic compounds having taste-modifying properties
|
|
US10674755B2
(en)
|
2013-10-02 |
2020-06-09 |
Givaudan S.A. |
Organic Compounds
|
|
GB201317424D0
(en)
|
2013-10-02 |
2013-11-13 |
Givaudan Sa |
Improvements in or relating to organic compounds
|
|
GB201409363D0
(en)
|
2014-05-27 |
2014-07-09 |
Avexxin As |
Skin cancer treatment
|
|
CA2958080A1
(en)
|
2014-08-18 |
2016-02-25 |
Ampio Pharmaceuticals, Inc. |
Treatment of joint conditions
|
|
CN115025079A
(zh)
|
2015-04-28 |
2022-09-09 |
普罗诺瓦生物医药挪威公司 |
结构增强的含硫脂肪酸在预防和/或治疗非酒精性脂肪性肝炎中的用途
|
|
HK1246669A1
(zh)
|
2015-06-22 |
2018-09-14 |
Ampio Pharmaceuticals, Inc. |
人血清白蛋白低分子量组分在疾病治疗中的应用
|
|
US11690825B2
(en)
|
2016-03-09 |
2023-07-04 |
Board Of Regents, The University Of Texas System |
20-HETE receptor (GPR75) antagonists and methods of use
|
|
GB201604316D0
(en)
|
2016-03-14 |
2016-04-27 |
Avexxin As |
Combination therapy
|
|
WO2018055062A1
(en)
|
2016-09-21 |
2018-03-29 |
Avexxin As |
Pharmaceutical composition
|
|
CA3084728A1
(en)
|
2017-12-06 |
2019-06-13 |
Basf As |
Fatty acid derivatives for treating non-alcoholic steatohepatitis
|